Tafamidis (Vyndagel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy

被引：0

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2020年 / 62卷 / 1590期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：16 / 16

页数：1

共 3 条

[1] Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis [J].

Gertz, Morie A. ;

Benson, Merrill D. ;

Dyck, Peter J. ;

Grogan, Martha ;

Coelho, Terresa ;

Cruz, Marcia ;

Berk, John L. ;

Plante-Bordeneuve, Violaine ;

Schmidt, Hartmut H. J. ;

Merlini, Giampaolo .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (21) :2451-2466

[2] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy [J].

Maurer, Mathew S. ;

Schwartz, Jeffrey H. ;

Gundapaneni, Balarama ;

Elliott, Perry M. ;

Merlini, Giampaolo ;

Waddington-Cruz, Marcia ;

Kristen, Arnt V. ;

Grogan, Martha ;

Witteles, Ronald ;

Damy, Thibaud ;

Drachman, Brian M. ;

Shah, Sanjiv J. ;

Hanna, Mazen ;

Judge, Daniel P. ;

Barsdorf, Alexandra I. ;

Huber, Peter ;

Patterson, Terrell A. ;

Riley, Steven ;

Schumacher, Jennifer ;

Stewart, Michelle ;

Sultan, Marla B. ;

Rapezzi, Claudio .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11) :1007-1016

[3] Transthyretin (TTR) Cardiac Amyloidosis [J].

Ruberg, Frederick L. ;

Berk, John L. .

CIRCULATION, 2012, 126 (10) :1286-1300

← 1 →